Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision)

• Published in: Clinical Pediatric Endocrinology Vol. 24; no. 3; pp. 107 - 133
• Main Authors: Mass Screening Committee, Japanese Society for Pediatric Endocrinology, and Japanese Society for Mass Screening, Nagasaki, Keisuke, Minamitani, Kanshi, Anzo, Makoto, Adachi, Masanori, Ishii, Tomohiro, Onigata, Kazumichi, Kusuda, Satoshi, Harada, Shohei, Horikawa, Reiko, Minagawa, Masanori, Mizuno, Haruo, Yamakami, Yuji, Fukushi, Masaru, Tajima, Toshihiro
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Society for Pediatric Endocrinology 01.07.2015
• Subjects: congenital hypothyroidism; guideline; mass screening; Original; congenital hypothyroidism; mass screening; guideline
• ISSN: 0918-5739; 1347-7358
• DOI: 10.1297/cpe.24.107

Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and treatment. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital hypothyroidism. The disease requires continuous treatment, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 guidelines were revised in the current document (hereinafter referred to as the Guidelines). Target disease/conditions: Primary congenital hypothyroidism. Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.